Chiappetta C, Della Rocca C, Di Cristofano C
Int J Mol Sci. 2025; 25(24.
PMID: 39769419
PMC: 11728052.
DOI: 10.3390/ijms252413657.
Cullum S, Vang H, Glover M, Alammarah H, Morton H, Pham N
Front Oncol. 2024; 14:1462930.
PMID: 39659799
PMC: 11628483.
DOI: 10.3389/fonc.2024.1462930.
Giannoukakos S, DAmbrosi S, Koppers-Lalic D, Gomez-Martin C, Fernandez A, Hackenberg M
Heliyon. 2024; 10(6):e27360.
PMID: 38515664
PMC: 10955244.
DOI: 10.1016/j.heliyon.2024.e27360.
Shireman J, Cheng L, Goel A, Garcia D, Partha S, Quinones-Hinojosa A
Front Oncol. 2023; 13:1266397.
PMID: 37916170
PMC: 10618006.
DOI: 10.3389/fonc.2023.1266397.
Lysenkova Wiklander M, Overnas E, Lagensjo J, Raine A, Petri A, Wiman A
BMC Res Notes. 2023; 16(1):265.
PMID: 37817248
PMC: 10566058.
DOI: 10.1186/s13104-023-06537-2.
A Systematic Review of the Heterogenous Gene Expression Patterns Associated with Multidrug Chemoresistance in Conventional Osteosarcoma.
Mthethwa P, Marais L, Ramsuran V, Aldous C
Genes (Basel). 2023; 14(4).
PMID: 37107591
PMC: 10137822.
DOI: 10.3390/genes14040832.
Immunotherapeutic Approaches in Ovarian Cancer.
Yoon H, Kim A, Jang H
Curr Issues Mol Biol. 2023; 45(2):1233-1249.
PMID: 36826026
PMC: 9955550.
DOI: 10.3390/cimb45020081.
Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
Nourieh M, Vibert R, Saint-Ghislain M, Cyrta J, Vincent-Salomon A
Histopathology. 2022; 82(1):162-169.
PMID: 36482269
PMC: 10108312.
DOI: 10.1111/his.14794.
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study.
Colosini A, Bernardi S, Foroni C, Pasinetti N, Guerini A, Russo D
Biomedicines. 2022; 10(6).
PMID: 35740343
PMC: 9219949.
DOI: 10.3390/biomedicines10061321.
Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma.
Osei-Bordom D, Sachdeva G, Christou N
Front Med (Lausanne). 2022; 8:788869.
PMID: 35096878
PMC: 8795626.
DOI: 10.3389/fmed.2021.788869.
Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H, Lee S
Int J Mol Sci. 2022; 23(1).
PMID: 35008642
PMC: 8745679.
DOI: 10.3390/ijms23010216.
Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America.
Salvo M, Gonzalez-Feliu E, Toro J, Gallegos I, Maureira I, Miranda-Gonzalez N
J Pers Med. 2021; 11(9).
PMID: 34575676
PMC: 8472524.
DOI: 10.3390/jpm11090899.
Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN): Early Clinical Results.
Ris F, Hellan M, Douissard J, Nieva J, Triponez F, Woo Y
Cancers (Basel). 2021; 13(16).
PMID: 34439258
PMC: 8392437.
DOI: 10.3390/cancers13164104.
Comparative genomic signatures in young and old Chinese patients with colorectal cancer.
Wang F, Cheng H, Zhang X, Shan L, Bai B, Chen K
Cancer Med. 2021; 10(13):4375-4386.
PMID: 34041865
PMC: 8267122.
DOI: 10.1002/cam4.3987.
Parental Access to Children's Raw Genomic Data in Canada: Legal Rights and Professional Responsibility.
Beauvais M, Thorogood A, Szego M, Senecal K, Zawati M, Knoppers B
Front Genet. 2021; 12:535340.
PMID: 33868358
PMC: 8044527.
DOI: 10.3389/fgene.2021.535340.
High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype.
Machlowska J, Kapusta P, Baj J, Morsink F, Wolkow P, Maciejewski R
Cancers (Basel). 2020; 12(7).
PMID: 32708070
PMC: 7409326.
DOI: 10.3390/cancers12071981.
Power analysis for RNA-Seq differential expression studies using generalized linear mixed effects models.
Yu L, Fernandez S, Brock G
BMC Bioinformatics. 2020; 21(1):198.
PMID: 32429934
PMC: 7236949.
DOI: 10.1186/s12859-020-3541-7.
Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?.
Groisberg R, Subbiah V
Expert Rev Precis Med Drug Dev. 2019; 3(3):205-213.
PMID: 31886407
PMC: 6934166.
DOI: 10.1080/23808993.2018.1480898.
Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H, Yu J, Kong D, Xu Y, Zhang Z, Shui J
Int J Oncol. 2019; 55(6):1237-1248.
PMID: 31638164
PMC: 6831193.
DOI: 10.3892/ijo.2019.4897.
Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer.
Yang H, Zhang J, Zhang L, Wen X, Luo Y, Yao D
Oncol Lett. 2019; 18(5):4762-4770.
PMID: 31611986
PMC: 6781496.
DOI: 10.3892/ol.2019.10791.